# Jim Carnall

Jim Carnall is a manufacturing and medical-device operations executive. Carnall led Command Medical Products as COO, president, and CEO, and says they are moving on from the CEO role while considering fractional work, board service, and coaching.

- Profile: https://b2binfluencer.marketing/creators/jim-carnall/
- LinkedIn: https://www.linkedin.com/in/jim-carnall-43a2561
- LinkedIn followers: 1,520
- Topics: leadership, manufacturing-workforce
- Based on 10 dated posts, latest 2026-10-07

## Summary

Most useful for direct fractional operations or board advice in medical-device manufacturing, especially during growth or ownership transition.

- Best for: A medical-device contract manufacturer seeking scoped advisory help during growth or ownership transition.
- Not for: A national sponsored LinkedIn campaign for broad awareness or measurable lead generation.
- Check first: Confirm references, examples of fractional advisory work, and independently verified results relevant to your needs.

### Takeaways

- Carnall led Command Medical Products as COO, president, and CEO.
- They describe a planned CEO handoff and staying to support a successor.
- They served on the Volusia Manufacturers Association board and did alliance volunteer work.

## Main ideas

- **Growth matters alongside a careful handover**: Carnall presents company growth and leadership continuity as linked responsibilities. In describing their departure from Command Medical Products, they credit the people who supported the company and say they would stay through the year to help the incoming CEO.
- **Manufacturing leadership includes giving back to the local industry**: Carnall connects long-term involvement in manufacturing with service to regional organizations. Their posts point to committee and board participation as ways to contribute, rather than focusing on personal visibility.
- **Medical-device quality work runs from development through production**: A Command Medical Products hiring post frames quality as a continuing, cross-functional responsibility—not a final inspection step. It covers both new products and products already in production, while naming compliance and improvement work.

## Work to read

- [47 Years in Manufacturing — and the Next Chapter](https://www.linkedin.com/posts/jim-carnall-43a2561_47-years-in-manufacturing-and-the-next-activity-7395094788469071872-35kh)
- [VMA Board of Directors announcement](https://www.linkedin.com/posts/jim-carnall-43a2561_vma-leadership-commandmedical-activity-7338957880596865024-ekg1)
- [Quality Engineer opening at Command Medical Products](https://www.linkedin.com/posts/jim-carnall-43a2561_command-medical-products-is-looking-for-an-activity-7330225531155529729-igLu)
- [VMA Manufacturing Alliance volunteer announcement](https://www.linkedin.com/posts/jim-carnall-43a2561_vma-activity-7392388298729594880-D8-O)

## Brand relationships

- **Kodak** (employment)
- **University of Florida Tissue Bank** (employment)
- **Regeneration Technologies Inc.** (owned_business)
- **ViewRay** (owned_business)
- **Command Medical Products** (employment)
- **Argosy Healthcare Partners** (investment)
- **Volusia Manufacturers Association** (affiliate)

## Partnerships

Jim Carnall's posts do not describe sponsored-content, affiliate, or media-partnership formats. The only engagement they state publicly is their own next chapter: they hope to stay involved through fractional roles, board work, or coaching after leaving the Command Medical Products CEO role. A brand or company approaching them would be negotiating a direct professional-services arrangement, not booking a defined media package. Their posts provide no rate card, scope document, sponsorship policy, or application process; ask about scope, deliverables, fees, time commitment, and commercial terms.

## Alternatives

- Pamela Shaddock: Choose Shaddock when the manufacturer's growth challenge sits on the hospital side of the business, not the factory floor: opening health-system accounts, reaching oncology and patient-services teams, selling through hospital retail, or understanding how insurance benefits and patient access shape adoption. Shaddock's posts describe co-founding Coils to Locs, a textured-wig company for medical hair loss, after a sister's breast-cancer treatment; building 27 or more hospital and cancer-center partnerships, with a stated goal of 40 by the end of 2026; running alopecia education webinars and a live conference panel with the National Alopecia Areata Foundation; and funding the work through an accelerator cohort, a community award, and a $25,000 grant. For a brief such as "help us win more hospital systems and understand the patient pathway," this firsthand provider and channel detail is more useful than a manufacturing operations background.
- Swati Garg: Choose Garg when the constraint is the commercial organization after the product, not production: which post-sale roles to hire, how to structure customer success and support, how AI is shifting skills and team design, and how to negotiate pay to retain scarce talent. Garg's posts cover the one-year anniversary of The Customer Success Talent Playbook, which Garg describes as an Amazon best seller; speaking and running a 90-minute mentorship workshop at NY Success Week; a customer-success compensation and negotiation webinar; and a cited ChurnZero finding that only 14% of budget will go to headcount over the next 12 to 18 months, with the conclusion that every hire now matters more. The posts also point to recruiting through Melo Associates. If the manufacturer's bottleneck is building a revenue or customer-facing team and hiring specialized roles, this material maps to the task more closely than an operations-and-transition record.
- Lee Odess: Choose Odess when the question is how to position a hardware product, which channels reach buyers who avoid the usual dealer network, how acquisitions reshape a category, or how regulation can become a competitive advantage. Odess's posts include an analysis of ASSA ABLOY's acquisition of Pacific Lock—the deal logic, the American-made manufacturing angle, and the argument that a distinctive brand color is an unexploited asset—and an episode arguing that GDPR, NIS2, and the Cyber Resilience Act work as product discipline and a market moat rather than an added tax. Odess also points to industry newsletters and a podcast. For a brief about category positioning, compliance-led differentiation, or reading acquisition patterns ahead of a sale, this market-analysis approach is closer to the need than a plant-leadership background.

---
AI-assisted summary of public posts. Audience demographics are not available. Engagement appears only where we checked recent posts. Method: https://b2binfluencer.marketing/methodology/